🧪 EXPERIMENTAL / ALPHA — this is an independent prototype, not an official record. Data may be incomplete or wrong - always check the linked Hansard source before relying on it.
Hot Air

Wednesday, 5 December 2018

Misuse of Drugs (Medicinal Cannabis) Amendment Bill

New Clause 4A New section 2A inserted (Meaning of CBD product)
HansardID: 89a90cfa-10c5-4d3d-87e8-453229befde3
Back to debates
📜 Official Hansard transcript
← Misuse of Drugs (Medicinal Cannabis) Amendment Bill Misuse of Drugs (Medicinal Cannabis) Amendment Bill →
🗣️ Speech Hon Dr David Clark (New Zealand Labour Party — Member for Dunedin North)
Time unknown

This is a very technical clause, and I fear that if I don’t speak up, no one will. This new provision contains the amended definition of “CBD product” allowing specified substances up to 2 percent of the cannabidiol (CBD) and specified substance content, where those substances have been defined as THCs and substances related to THCs that are capable of producing more than a minor psychoactive effect. It’s a technical clause but an important one.

The question was put that the amendment set out on Supplementary Order Paper 177 in the name of the Hon Dr David Clark to insert new clause 4A be agreed to.

Amendment agreed to.

Clause 5 Section 7 amended (Possession and use of controlled drugs)

🗣️ Spoke in this debate (1)